304 filings
Page 4 of 16
4
mxq6nwt4nbjokz19q
15 Feb 19
GW PHARMACEUTICALS / Justin D. Gover ownership change
4:31pm
SC 13G/A
zz0ga53x53ccwqm0vo2
14 Feb 19
GW Pharmaceuticals PLC
3:24pm
SC 13G
snv1x16fmuiw2 uul
14 Feb 19
GW Pharmaceuticals PLC
12:00am
SC 13G/A
2akzqual3z
14 Feb 19
GW Pharmaceuticals PLC
12:00am
SC 13G/A
z3f2a8
14 Feb 19
GW Pharmaceuticals PLC
12:00am
SC 13G/A
fbw oe5qk2
14 Feb 19
GW Pharmaceuticals PLC
12:00am
S-3ASR
8nm8klh72f4rdj9pi
18 Jan 19
Automatic shelf registration
5:01pm
8-K
ps2uc8v
7 Jan 19
Regulation FD Disclosure
6:13am
4
2ojl5sbh yag
4 Jan 19
GW PHARMACEUTICALS / Justin D. Gover ownership change
4:15pm
4
56qpndu6d6e5gl 574
26 Dec 18
GW PHARMACEUTICALS / Justin D. Gover ownership change
4:15pm
10-K
vwyu f5ddm88p
28 Nov 18
Annual report
8:58pm
8-K
1ezg8uaf cffc
27 Nov 18
GW Pharmaceuticals plc Reports Fiscal Fourth Quarter and Year-End 2018 Financial Results and Operational Progress
4:05pm
8-K
tk2ne 29spndlhu1
26 Nov 18
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome
4:15pm
4
fhjrnv2zbe69uzxi0j7
23 Nov 18
GW PHARMACEUTICALS / Adam D. George ownership change
4:30pm
8-K
v4ufgr1j5k adbukk0r
5 Oct 18
GW Pharmaceuticals plc Announces Pricing of Public Offering of ADSs
5:08pm
424B5
fdba0
3 Oct 18
Prospectus supplement for primary offering
5:30pm
8-K
9kqrah7d i5
1 Oct 18
Other Events
4:14pm
424B5
2oxtg
1 Oct 18
Prospectus supplement for primary offering
4:12pm
3
3sktm0 o92nu8z8jz
1 Oct 18
GW PHARMACEUTICALS / Cabot Brown ownership change
12:00am
3
v7kpz356tnu
1 Oct 18
GW PHARMACEUTICALS / Justin D. Gover ownership change
12:00am